DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

12.00 -0.30 (-2.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SRPT $12.00 -2.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.19
Previous Close $12.30
Daily Range $12.00 - $12.54
52-Week Range $11.33 - $40.00
Market Cap $495.7M
P/E Ratio -5.02
Dividend (Yield) $0.00 (0.0%)
Volume 524,074
Average Daily Volume 1,062,494
Current FY EPS -$3.16





Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website:

News & Commentary

State of the Union Address Investing Idea: Precision Medicine

There are plenty of companies developing precision medicine drugs already, and investors would be wise to watch key players.

Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog

Sarepta Is Suffering From Overreaction

Sarepta Therapeutics Slumps: SRPT Falls 14.6% in Session - Tale of the Tape

Today's Dead Cat Bounce Stock: Sarepta Therapeutics (SRPT)

Big Short Interest On These 5 Biotech Stocks

BioMarin Shows Up Rival Sarepta During 'JPM15' Investor Presentation

Why Sarepta Theraputics Inc's Shares Crashed

Is this meaningful? Or just another movement?

Sarepta Therapeutics (SRPT) Stock Hits One-Year Low Today After Eteplirsen Update

Stocks Hitting 52-Week Lows

See More SRPT News...

SRPT's Top Competitors

SRPT $12.00 (-2.44%)
Current stock: SRPT
AMGN $152.26 (-2.63%)
Current stock: AMGN
GILD $104.83 (0.62%)
Current stock: GILD
BIIB $389.16 (10.17%)
Current stock: BIIB